Ivosidenib (AG-120) in mutant IDH1 AML and advanced hematologic malignancies: Results of a phase 1 dose escalation and expansion study Meeting Abstract
| Authors: | DiNardo, C. D.; De Botton, S.; Stein, E. M.; Roboz, G. J.; Mims, A. S.; Pollyea, D. A.; Swords, R. T.; Altman, J. K.; Collins, R. H.; Mannis, G. N.; Uy, G. L.; Donnellan, W.; Pigneux, A.; Fathi, A. T.; Stein, A. S.; Erba, H. P.; Prince, G. T.; Foran, J. M.; Traer, E.; Stuart, R. K.; Arellano, M. L.; Slack, J. L.; Sekeres, M. A.; Yen, K.; Kapsalis, S. M.; Liu, H.; Goldwasser, M.; Agresta, S.; Attar, E. C.; Tallman, M. S.; Stone, R. M.; Kantarjian, H. M. |
| Abstract Title: | Ivosidenib (AG-120) in mutant IDH1 AML and advanced hematologic malignancies: Results of a phase 1 dose escalation and expansion study |
| Meeting Title: | 59th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 130 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2017 Dec 9-12 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2017-12-07 |
| Language: | English |
| ACCESSION: | WOS:000432419401372 |
| PROVIDER: | Clarivate Analytics Web of Science |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V130.Suppl_1.725.725 |
| Notes: | Meeting Abstract: 725 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work